UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Molecular and cellular mechanisms underlying brain metastasis of breast cancer

Cancer and metastasis reviews, 2020-09, Vol.39 (3), p.711-720

2020

Link zum Volltext

Verfügbarkeit prüfen

Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer

Cancer science, 2022-05, Vol.113 (5), p.1808-1820

2022

Link zum Volltext

Verfügbarkeit prüfen

Assessment of a cancer genomic profile test for patients with metastatic breast cancer

Scientific reports, 2022-03, Vol.12 (1), p.4813-4813, Article 4813

2022

Link zum Volltext

Verfügbarkeit prüfen

Expression of CD24 is associated with HER2 expression and supports HER2‐Akt signaling in HER2‐positive breast cancer cells

Cancer science, 2014-07, Vol.105 (7), p.779-787

2014

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of an inflammation-based score for identification of appropriate patients for comprehensive genomic profiling

Discover. Oncology, 2022-10, Vol.13 (1), p.109-109, Article 109

2022

Link zum Volltext

Verfügbarkeit prüfen

HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer

International journal of molecular sciences, 2018-07, Vol.19 (8), p.2158

2018

Link zum Volltext

Verfügbarkeit prüfen

Induction of ZEB Proteins by Inactivation of RB Protein Is Key Determinant of Mesenchymal Phenotype of Breast Cancer

The Journal of biological chemistry, 2012-03, Vol.287 (11), p.7896-7906

2012

Link zum Volltext

Verfügbarkeit prüfen

RNA Sequencing Analysis Reveals Interactions between Breast Cancer or Melanoma Cells and the Tissue Microenvironment during Brain Metastasis

BioMed research international, 2017-01, Vol.2017, p.8032910-10

2017

Link zum Volltext

Verfügbarkeit prüfen

Influence of menopause on chemotherapy‐induced nausea and vomiting in highly emetogenic chemotherapy for breast cancer: A retrospective observational study

Cancer medicine (Malden, MA), 2023-09, Vol.12 (18), p.18745-18754

2023

Link zum Volltext

Verfügbarkeit prüfen

Hereditary breast cancer associated with Cowden syndrome-related PTEN mutation with Lhermitte-Duclos disease

Surgical case reports, 2017-07, Vol.3 (1), p.83-83, Article 83

2017

Link zum Volltext

Verfügbarkeit prüfen

A lower dose of docetaxel at 60 mg/m2 could be continued longer for controlling peripheral edema in patients with metastatic breast cancer

Breast cancer (Tokyo, Japan), 2012-10, Vol.19 (4), p.329-334

2012

Link zum Volltext

Verfügbarkeit prüfen

Prognostic impact of cancer genomic profile testing for advanced or metastatic solid tumors in clinical practice

Cancer science, 2023-12, Vol.114 (12), p.4632-4642

2023

Link zum Volltext

Verfügbarkeit prüfen

MO9-5 Clinical implementation of cancer genomic medicine using gene profiling test under national health insurance in Japan

Annals of oncology, 2021-07, Vol.32, p.S301-S301

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-15-02: Low incidence of hepatitis B reactivation after chemotherapy in Japanese breast cancer patients with resolved HBV

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P1-P1-15-02

2022

Link zum Volltext

Verfügbarkeit prüfen

Prospective observational study to evaluate lemborexant utility in insomnia among women with breast cancer (WJOG14921B, LUNAR study)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.TPS12148-TPS12148

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3331: CD24 promotes HER2 signaling pathways and CD24 inhibition sensitizes anti-HER2 therapy in breast cancer

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.3331-3331

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract PS12-10: Phase II study of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR+, HER2- metastatic breast cancer: WJOG11418B NEWFLAME trial

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.PS12-10-PS12-10

2021

Link zum Volltext

Verfügbarkeit prüfen

MO33-7 Preparedness for COVID-19 pandemic and impact on medical oncology for breast cancer

Annals of oncology, 2021-07, Vol.32, p.S320-S320

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 522: The epithelial-mesenchymal transition-related transcription factor ZEB suppresses Claudin expression in breast cancer cells

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.522-522

2013

Link zum Volltext

Verfügbarkeit prüfen

Characteristics and prognosis of leptomeningeal metastasis in patients with breast cancer

Annals of oncology, 2019-10, Vol.30, p.vi113

2019

Link zum Volltext

Verfügbarkeit prüfen

Role of CD24 in HER2-positive breast cancer

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e11572-e11572

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract P5-01-15: Monitoring of CDK4/6 inhibitor treatment response through blood liquid biopsy in metastatic breast cancer

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P5-P5-01-15

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparison of CEF (C: cyclophosphamide, E: epirubicin, and 5FU) and EC (E: epirubicin and C: cyclophosphamide) therapy in neoadjuvant setting for axillary lymph node metastasis-positive breast cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e12520-e12520

2016

Link zum Volltext

Verfügbarkeit prüfen

Availability of genome-matched therapy based on clinical practice

International journal of clinical oncology, 2024-04

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Molecular and cellular mechanisms underlying brain metastasis of breast cancer

Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer

Assessment of a cancer genomic profile test for patients with metastatic breast cancer

Expression of CD24 is associated with HER2 expression and supports HER2‐Akt signaling in HER2‐positive breast cancer cells

Evaluation of an inflammation-based score for identification of appropriate patients for comprehensive genomic profiling

HER2 Heterogeneity Is Associated with Poor Survival in HER2-Positive Breast Cancer

Induction of ZEB Proteins by Inactivation of RB Protein Is Key Determinant of Mesenchymal Phenotype of Breast Cancer

RNA Sequencing Analysis Reveals Interactions between Breast Cancer or Melanoma Cells and the Tissue Microenvironment during Brain Metastasis

Influence of menopause on chemotherapy‐induced nausea and vomiting in highly emetogenic chemotherapy for breast cancer: A retrospective observational study

Efficacy, safety, and biomarker analysis of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR-positive HER2-negative metastatic breast cancer: a phase II study (WJOG11418B NEWFLAME trial)

Hereditary breast cancer associated with Cowden syndrome-related PTEN mutation with Lhermitte-Duclos disease

A lower dose of docetaxel at 60 mg/m2 could be continued longer for controlling peripheral edema in patients with metastatic breast cancer

Prognostic impact of cancer genomic profile testing for advanced or metastatic solid tumors in clinical practice

MO9-5 Clinical implementation of cancer genomic medicine using gene profiling test under national health insurance in Japan

Abstract P1-15-02: Low incidence of hepatitis B reactivation after chemotherapy in Japanese breast cancer patients with resolved HBV

Prospective observational study to evaluate lemborexant utility in insomnia among women with breast cancer (WJOG14921B, LUNAR study)

Abstract 3331: CD24 promotes HER2 signaling pathways and CD24 inhibition sensitizes anti-HER2 therapy in breast cancer

Abstract PS12-10: Phase II study of nivolumab in combination with abemaciclib plus endocrine therapy in patients with HR+, HER2- metastatic breast cancer: WJOG11418B NEWFLAME trial

MO33-7 Preparedness for COVID-19 pandemic and impact on medical oncology for breast cancer

Abstract 522: The epithelial-mesenchymal transition-related transcription factor ZEB suppresses Claudin expression in breast cancer cells

Characteristics and prognosis of leptomeningeal metastasis in patients with breast cancer

Role of CD24 in HER2-positive breast cancer

Abstract P5-01-15: Monitoring of CDK4/6 inhibitor treatment response through blood liquid biopsy in metastatic breast cancer

Comparison of CEF (C: cyclophosphamide, E: epirubicin, and 5FU) and EC (E: epirubicin and C: cyclophosphamide) therapy in neoadjuvant setting for axillary lymph node metastasis-positive breast cancer

Availability of genome-matched therapy based on clinical practice

Suchergebnisse filtern